EUVIMEDEUVIMED entdecken
Open Access

Prediction for recurrent non-muscle invasive bladder cancer

Keqiang Li, Aravind Raveendran, Guoqing Xie, Yu Zhang, Haofan Wu, Zhenlin Huang, Zhankui Jia, Jinjian Yang

Cancer Biomarkers · 20.11.2023 · 38 (3) · 275-285

DOI: 10.3233/cbm-220373 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biomarkers, erschienen am 20.11.2023. Verfasst von Keqiang Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Urology, Department of Urology, The First Affiliated Hospital of Zhengzhou University, Henan, China. Hauptthemen laut MEDLINE: Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-muscle invasive bladder cancer (NMIBC) has a high recurrence rate, which places a significant burden on both patients and the healthcare system. Hence, it holds significant importance to predict the recurrence risk following treatment for individuals diagnosed with non-muscle invasive bladder cancer (NMIBC). As new generation technologies continue to emerge, an increasing number of recurrence risk prediction tools are being developed and discovered. This article provides an overview of the primary recurrence risk prediction tools currently available, including the liquid biopsy, tissue biopsy, and risk prediction tables. Each of these tools is described in detail and illustrated with relevant examples. Furthermore, we conduct an analysis of the advantages and disadvantages of these tools. This article aims to enhance the reader’s understanding of the current progress in recurrence prediction tools and encourage their practical utilization in the fields of precision medicine and public health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-Muscle Invasive Bladder NeoplasmsUrinary Bladder NeoplasmsHumansBiopsyLiquid BiopsyPrecision Medicine

Stichwörter der Autor:innen

Bladder cancerNMIBCbiopsypredictionrecurrence

Autor:innen und Institutionen

  • Laboratory Urology, Department of Urology, The First Affiliated Hospital of Zhengzhou University, Henan, China.
  • Academy of Medical Sciences, Zhengzhou University, Henan, China.
  • Department of Gastrointestinal Surgery, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.

Zitieren

APA

Li, K., Raveendran, A., Xie, G., Zhang, Y., Wu, H., Huang, Z., Jia, Z., & Yang, J. (2023). Prediction for recurrent non-muscle invasive bladder cancer. Cancer Biomarkers, 38(3), 275-285. https://doi.org/10.3233/cbm-220373

Vancouver

Li K, Raveendran A, Xie G, Zhang Y, Wu H, Huang Z, et al. Prediction for recurrent non-muscle invasive bladder cancer. Cancer Biomarkers. 2023;38(3):275-285. doi:10.3233/cbm-220373

BibTeX
@article{Li2023,
  author = {Li, Keqiang and Raveendran, Aravind and Xie, Guoqing and Zhang, Yu and Wu, Haofan and Huang, Zhenlin and Jia, Zhankui and Yang, Jinjian},
  title = {Prediction for recurrent non-muscle invasive bladder cancer},
  journal = {Cancer Biomarkers},
  year = {2023},
  volume = {38},
  number = {3},
  pages = {275--285},
  doi = {10.3233/cbm-220373}
}
Kostenlos starten →